Effect of Weekly Subcutaneous Semaglutide on liver steatosis and fibrosis indexes (fatty liver disease?) in patients with diabetes and obesity Academic Article 2022 uri icon

authors

  • Juana Carretero Gómez
  • Francisco Javier Carrasco Sánchez
  • José María Fernández Rodríguez
  • Pedro Casado Escribano
  • José Pablo Miramontes González
  • SEGUI RIPOLL, JOSE MIGUEL
  • Javier Ena
  • Jose Carlos Arévalo Lorido
  • on Belhaf of Diabetes Obesity and Nutrition Working Group of Spanish Society of Internal Medicine

publication date

  • 2022